ZHU Wenli, WANG Dongling, HOU Sicong, LI Jiajia. Chinese version of the Nine-Item Avoidant/Restrictive Food Intake Disorder Scale in patients with inflammatory bowel disease: a test of reliability and validity[J]. Journal of Clinical Medicine in Practice, 2024, 28(1): 108-112, 117. DOI: 10.7619/jcmp.20233187
Citation: ZHU Wenli, WANG Dongling, HOU Sicong, LI Jiajia. Chinese version of the Nine-Item Avoidant/Restrictive Food Intake Disorder Scale in patients with inflammatory bowel disease: a test of reliability and validity[J]. Journal of Clinical Medicine in Practice, 2024, 28(1): 108-112, 117. DOI: 10.7619/jcmp.20233187

Chinese version of the Nine-Item Avoidant/Restrictive Food Intake Disorder Scale in patients with inflammatory bowel disease: a test of reliability and validity

More Information
  • Received Date: October 09, 2023
  • Revised Date: November 30, 2023
  • Available Online: January 22, 2024
  • Objective 

    To test the reliability and validity of the Chinese version of the Nine-Item Avoidant/Restrictive Food Intake Disorder Scale (NIAS) in patients with inflammatory bowel disease (IBD).

    Methods 

    Based on convenience sampling method, 304 patients from the Treatment Center for Inflammatory Bowel Disease of two Grade Ⅲ Level hospitals A in Jiangsu Province were selected as the research objects, and they were investigated by a general information questionnaire, NIAS, and the Satisfaction with Food-Related Life (SWFL). Item analysis (discrimination analysis, correlation coefficient) and reliability analysis of the total scale and subscales (Cronbach's α coefficient) were performed. Exploratory factor analysis, confirmatory factor analysis, criterion-related validity, convergent validity, and discriminant validity were used to test the validity of the scale.

    Results 

    The Chinese version of NIAS contained 9 items, including 3 subscales of picky eating, appetite and fear; the confirmatory factor analysis indicated a good construct validity in 3-factor model[χ2/df=2.340, root mean square error of approximation (RMSEA)=0.078, standardized root mean square residual (SRMR)=0.046, incremental fit index (IFI)=0.969, comparative fit index (CFI)=0.969, normed fit index (NFI)=0.948, goodness of fit index (GFI)=0.951, the Tucker-Lewis index (TLI)=0.951]; the correlation coefficient between the total score of the Chinese version of NIAS and the SWFL scale was -0.353, indicating a strong correlation; the aggregated validity CR values for each dimension of the scale were 0.821 to 0.855, and the AVE values were 0.606 for appetite, 0.621 for picky eating, and 0.664 for fear. The total Cronbach's α coefficient of the Chinese version of the NIAS scale was 0.82, and the Cronbach's α coefficients for dimensions of picky eating, appetite and fear were 0.87, 0.71 and 0.92 respectively, indicating the Chinese version of the NIAS scale had good internal consistency and stability.

    Conclusion 

    The Chinese version of the NIAS scale has good reliability and validity, and can be used to evaluate avoidant and restrictive food intake disorder behaviors in IBD patients.

  • [1]
    LENNARD-JONES J E. Classification of inflammatory bowel disease[J]. Scand J Gastroenterol Suppl, 1989, 170: 2-6, 16-19.
    [2]
    吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中国实用内科杂志, 2018, 38(9): 796-813.
    [3]
    KAPLAN G G. The global burden of IBD: from 2015 to 2025[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(12): 720-727. doi: 10.1038/nrgastro.2015.150
    [4]
    BEN-HORIN S, CASTEELE N V, SCHREIBER S, et al. Biosimilars in Inflammatory Bowel Disease: Facts and Fears of Extrapolation[J]. Clinical Gastroenterology and Hepatology, 2016, 14(12): 1685-1696. doi: 10.1016/j.cgh.2016.05.023
    [5]
    ANANTHAKRISHNAN A N. Epidemiology and risk factors for IBD[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(4): 205-217. doi: 10.1038/nrgastro.2015.34
    [6]
    MARTINEZ-MEDINA M, DENIZOT J, DREUX N, et al. Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation[J]. Gut, 2014, 63(1): 116-124. doi: 10.1136/gutjnl-2012-304119
    [7]
    SUGIHARA K, MORHARDT T L, KAMADA N. The role of dietary nutrients in inflammatory bowel disease[J]. Front Immunol, 2019, 9: 3183. doi: 10.3389/fimmu.2018.03183
    [8]
    DE VRIES J H M, DIJKHUIZEN M, TAP P, et al. Patient's dietary beliefs and behaviours in inflammatory bowel disease[J]. Dig Dis, 2019, 37(2): 131-139. doi: 10.1159/000494022
    [9]
    CROOKS B, MISRA R, AREBI N, et al. The dietary practices and beliefs of British South Asian people living with inflammatory bowel disease: a multicenter study from the United Kingdom[J]. Intest Res, 2022, 20(1): 53-63. doi: 10.5217/ir.2020.00079
    [10]
    BERGERON F, BOUIN M, D'AOUST L, et al. Food avoidance in patients with inflammatory bowel disease: what, when and who[J]. Clin Nutr, 2018, 37(3): 884-889. doi: 10.1016/j.clnu.2017.03.010
    [11]
    KOCSIS R N. Book review: diagnostic and statistical manual of mental disorders: (DSM-5)[Z]. Sage Publications Sage CA: Los Angeles, 2013: 1-31.
    [12]
    FINK M, SIMONS M, TOMASINO K, et al. When is patient behavior indicative of avoidant restrictive food intake disorder (ARFID) vs reasonable response to digestive disease?[J]. Clin Gastroenterol Hepatol, 2022, 20(6): 1241-1250. doi: 10.1016/j.cgh.2021.07.045
    [13]
    YELENCICH E, TRUONG E, WIDAMAN A M, et al. Avoidant restrictive food intake disorder prevalent among patients with inflammatory bowel disease[J]. Clin Gastroenterol Hepatol, 2022, 20(6): 1282-1289, e1. doi: 10.1016/j.cgh.2021.08.009
    [14]
    HE J B, ZICKGRAF H F, ELLIS J M, et al. Chinese version of the nine item ARFID screen: psychometric properties and cross-cultural measurement invariance[J]. Assessment, 2021, 28(2): 537-550. doi: 10.1177/1073191120936359
    [15]
    ELLIS J, ZICKGRAF H F, WHITED M C, et al. Establishing clinical cutoffs for the screening of avoidant/restrictive food intake disorder; proceedings of the Annals of Behavioral Medicine, F, 2017[C]. SPRINGER 233 SPRING ST, NEW YORK, NY 10013 USA.
    [16]
    GRUNERT K G, DEAN M, RAATS M M, et al. A measure of satisfaction with food-related life[J]. Appetite, 2007, 49(2): 486-493. doi: 10.1016/j.appet.2007.03.010
    [17]
    HE J B, ELLIS J M, ZICKGRAF H F, et al. Translating, modifying, and validating the adult picky eating questionnaire for use in China[J]. Eat Behav, 2019, 33: 78-84. doi: 10.1016/j.eatbeh.2019.04.002
    [18]
    吴明隆. 问卷统计分析实务: SPSS操作与应用[M]. 重庆: 重庆大学出版社, 2010: 21-54.
    [19]
    吴明隆. 结构方程模型: SIMPLIS的应用[M]. 重庆: 重庆大学出版社, 2012: 25-41.
    [20]
    林崇德. 心理学大辞典[M]. 上海: 上海教育出版社, 2003: 1-31.
    [21]
    FLETCHER P C, SCHNEIDER M A. Is there any food I can eat Living with inflammatory bowel disease and/or irritable bowel syndrome[J]. Clin Nurse Spec, 2006, 20(5): 241-247. doi: 10.1097/00002800-200609000-00011
  • Related Articles

    [1]MENG Xiangzhong, WEI Feng, WANG Na, SHI Zhenhua, DING Dongrui. Clinical analysis of plasma procalcitonin and C-reactive protein levels in 65 patients with septic shock[J]. Journal of Clinical Medicine in Practice, 2018, (3): 120-122. DOI: 10.7619/jcmp.201803035
    [2]REN Wenjun, LIU Xiaolan. Value of serum procalcitonin in prognosis diagnosis of patients with sepsis[J]. Journal of Clinical Medicine in Practice, 2016, (21): 48-51. DOI: 10.7619/jcmp.201621015
    [3]LI Zhi. Changes and diagnostic value of serum procalcitonin and C-reactive protein in patients with severe infection in ICU[J]. Journal of Clinical Medicine in Practice, 2016, (5): 70-72. DOI: 10.7619/jcmp.201605021
    [4]ZHNG Geng, DENG Bingqu, ZHAN Daliang. Predictive value of serum procalcitonin in diagnosis and prognosis for aged patients with community-acquired pneumonia[J]. Journal of Clinical Medicine in Practice, 2015, (23): 37-40. DOI: 10.7619/jcmp.201523012
    [5]LIU Chijia, CUI Yuntao, ZHANG Aimin. Change and significance of serum procalcitonin and C-reactive protein levels in cerebral hemorrhage patients complicated with infection[J]. Journal of Clinical Medicine in Practice, 2015, (13): 27-29. DOI: 10.7619/jcmp.201513008
    [6]XU Bin, FAN Zhigang, YANG Yun, XU Zongxian. Application of serum procalcitonin and C-reactive protein detections in the diagnosis of neonatal severe infectious disease[J]. Journal of Clinical Medicine in Practice, 2014, (24): 50-52. DOI: 10.7619/jcmp.201424015
    [7]LI Yuanhua, SONG Xiuchan, QI Yingjing, ZENG Peiyang, WU Suhua, LAI Zhijun, XIE Shufeng. Value of plasma procalcitonin level detection in treatment of pyemia[J]. Journal of Clinical Medicine in Practice, 2014, (15): 155-157. DOI: 10.7619/jcmp.201415054
    [8]CHEN Jun, XHAO Lan, BI Jing. Clinical significance of serum procalcitonin and IL-6 detection in diagnosis and treatment of patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2014, (9): 144-145. DOI: 10.7619/jcmp.201409050
    [9]TANG Haicheng, BO Hongjian, ZHOU Zhixiang, ZHANG Qun, JIANG Yongqian, MA Da. Clinical significance of serum procalcitonin detection in antibiotic treatment of patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2013, (24): 16-19,23. DOI: 10.7619/jcmp.201324005
    [10]YU Lan, ZHANG Jifang, LI Yunfang. Application of cefoperazone/sulbactam sodium in the prevention and treatment of obstetric and gynecological infections[J]. Journal of Clinical Medicine in Practice, 2013, (14): 68-70. DOI: 10.7619/jcmp.201314023

Catalog

    Article views (118) PDF downloads (6) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return